Benzinga's Top Upgrades
Analysts at Piper Jaffray upgraded Fusion-io (NYSE: FIO) from “neutral” to “overweight.” The target price for Fusion-io has been raised from $12 to $17. Fusion-io's shares closed at $13.60 yesterday.
Analysts at JP Morgan upgraded Marvell Technology Group (NASDAQ: MRVL) from “neutral” to “overweight.” The target price for Marvell Technology Group has been raised from $14 to $16. Marvell Technology's shares closed at $12.57 yesterday.
Analysts at Morgan Stanley upgraded Biomed Realty Trust (NYSE: BMR) from “equal-weight” to “overweight.” The target price for Biomed Realty Trust is set to $23. Biomed Realty Trust's shares closed at $18.61 yesterday.
Analysts at Citigroup upgraded M.D.C. Holdings (NYSE: MDC) from “sell” to “neutral.” The target price for M.D.C. Holdings has been raised from $23 to $29. M.D.C. Holdings' shares closed at $29.37 yesterday.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.